National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

Neumega (noo-MEH-guh)

 A drug used to increase the number of blood cells, especially platelets, in some cancer patients receiving chemotherapy. Neumega is a form of interleukin-11 (a cytokine normally made by support cells in the bone marrow) that is made in the laboratory. It is a type of biological response modifier. Also called oprelvekin, recombinant human interleukin-11, and rhIL-11.



Previous Definitions:nerve growth factor, nerve-sparing radical prostatectomy, nerve-sparing surgery, nervous system, Neulasta
Next Definitions:neural, neuro-oncologist, neurobehavioral, neuroblastoma, neurocognitive

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov